January 30, 2026
Migraine Australia Pre-Budget Submission 2026–27
Migraine Australia’s 2026–27 Pre-Budget Submission outlines scalable reforms to improve equitable access to migraine care, reduce avoidable disability, and strengthen workforce participation.
Read moreFebruary 13, 2025
Deloitte Access Economics - Migraine in Australia Whitepaper
In 2018, Deloitte Access Economics prepared a whitepaper for Novartis Australia. Migraine is a neurological condition that affects 4.9 million Australians. Migraine is characterised by recurrent attacks of moderate to severe...
Read more